학술논문

Characterization and Management of Adverse Reactions in Patients With Advanced Endometrial Cancer Receiving Lenvatinib Plus Pembrolizumab
Document Type
Journal
Source
ONCOLOGIST; JUL 31 2023, 11p.
Subject
Language
English
ISSN
1549490X